文献速递脊柱关节炎

早期中轴型脊柱关节炎肠道通透性与细菌易位标志物与5年结局的关系

Bacterial translocation and intestinal permeability in early axial spondyloarthritis association with 5-year outcomes: insights from the DESIR cohort.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

基于DESIR队列297例早期中轴型脊柱关节炎患者,评估基线肠道通透性(zonulin)与细菌易位(LPS来源3-羟基肉豆蔻酸、PLTP)标志物与5年随访中肌肉骨骼外表现及影像学进展的关联。结果显示这些标志物与EMM无关联,但PLTP活性与骶髂关节炎症及影像学进展相关。

要点

  • 基线PLTP活性与基线SPARCC骶髂关节评分正相关,校正年龄、性别和CRP后仍显著。
  • 基线PLTP活性在影像学骶髂关节炎进展者中更高,校正后关联持续存在。
  • 基线zonulin、3-羟基肉豆蔻酸及PLTP与EMM的发生或存在均无关联。

核心结论

  • PLTP活性是近期起病axSpA中与骶髂关节炎症及5年影像学进展相关的有前景的生物标志物。

研究设计与样本

  • DESIR队列中297例有5年临床数据的axSpA患者,检测基线血清zonulin、LPS来源3-羟基肉豆蔻酸和PLTP水平,用单因素和多因素logistic回归分析其与EMM及影像学评分的关联。

主要发现

  • 基线zonulin在有基线影像学骶髂关节炎者中更低(88.1 vs 140.6 ng/ml,P < 0.001),但多因素线性回归未证实。
  • PLTP活性与基线SPARCC骶髂关节评分正相关(β = 0.61,P = 0.02),校正年龄、性别和CRP后仍显著(β = 0.58,P = 0.03)。
  • 影像学骶髂关节炎进展者PLTP活性更高(6.1 vs 5.2 nmol/h/ml,P = 0.02),校正后关联持续(β = 0.27,P = 0.02)。
  • 基线3-羟基肉豆蔻酸、PLTP活性和zonulin与EMM的存在或发生率均无关联。

关键数值与推荐

  • 基线zonulin在有与无基线影像学骶髂关节炎者中分别为88.1与140.6 ng/ml(P < 0.001)。
  • PLTP活性与基线SPARCC骶髂关节评分关联:未校正β = 0.61(P = 0.02),校正后β = 0.58(P = 0.03)。
  • 影像学骶髂关节炎进展者与非进展者PLTP活性分别为6.1与5.2 nmol/h/ml(P = 0.02),校正后β = 0.27(P = 0.02)。

临床怎么用

  • 在早期axSpA中可关注PLTP活性作为骶髂关节炎症和影像学进展的潜在血清标志物,但尚不能替代影像学评估。
  • zonulin和LPS来源3-羟基肉豆蔻酸在本队列中未显示与EMM或影像学进展的稳定关联,不宜据此常规检测。

局限性

  • 本研究为观察性队列分析, PLTP与结局的关联不能推断因果关系。
  • zonulin与基线影像学骶髂关节炎的关联在多因素分析中未获证实,提示结果可能受混杂因素影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the association between initial serological markers of intestinal permeability (IP) and bacterial translocation (BT), and the development of extra-musculoskeletal manifestations (EMMs) and radiographic progression in axial spondyloarthritis (axSpA). METHODS: Serum samples from axSpA patients included in the DESIR cohort with clinical data available at 5 years were analysed. Gut permeability was assessed by zonulin levels and BT was assessed by lipopolysaccharide (LPS)-derived 3-hydroxymyristate and phospholipid transferase protein (PLTP) levels. The associations of baseline serological markers with the presence of EMM and imaging SI scores were analysed both at baseline and as primary outcomes of disease progression after 5 years follow-up. Associations were tested using univariate and multivariate logistic regression analyses. RESULTS: A total of 297 patients were included (mean age 31.5 ± 7.4 years; 48.5% female; 88.9% HLA-B27 positive). Baseline levels of 3-hydroxymyristate, PLTP activity and zonulin showed no association with the presence or incidence of EMM. Baseline zonulin levels were lower in patients with baseline radiographic sacroiliitis (88.1 vs 140.6 ng/ml, P < 0.001), though this was not confirmed in multivariate linear regression. PLTP activity was positively correlated with the baseline SPARCC SI joint score (β = 0.61, P = 0.02), and this association remained significant after adjusting for age, sex and CRP (β = 0.58, P = 0.03). Moreover, PLTP activity was significantly higher in patients with radiographic sacroiliitis progression (6.1 vs 5.2 nmol/h/ml, P = 0.02), an effect maintained after adjustment (β = 0.27, P = 0.02). CONCLUSION: PLTP activity is a promising biomarker associated with SI joint inflammation and radiographic progression over 5 years in recent axSpA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Verhoeven F, Fakih O, Hecquet S, et al. Bacterial translocation and intestinal permeability in early axial spondyloarthritis association with 5-year outcomes: insights from the DESIR cohort. Rheumatology (Oxford). 2026. PMID: 42018755. doi:10.1093/rheumatology/keag220

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。